Page 17 - nutrition
P. 17

Maturitas 143 (2021) 1–9
         H. Shakoor et al.
            P. Katsaounou, Complex immune dysregulation in COVID-19 patients with severe   [35] R.Z. Cheng, Can early and high intravenous dose of vitamin C prevent and treat
            respiratory failure, Cell Host Microbe 6 (2020) 992–1000.   coronavirus disease 2019 (COVID-19)? Med. Drug Discov. 5 (2020), 100028.
         [14] S. Gorman, A.G. Buckley, K.M. Ling, L.J. Berry, V.S. Fear, S.M. Stick, A.   [36] V.S. Biaggio, M.V. P´ erez Chaca, S.R. Vald´ ez, N.N. G´ omez, M.S. Gimenez, Alteration
            N. Larcombe, A. Kicic, P.H. Hart, Vitamin D supplementation of initially vitamin D-   in the expression of inflammatory parameters as a result of oxidative stress
            deficient mice diminishes lung inflammation with limited effects on pulmonary   produced by moderate zinc deficiency in rat lung, Exp. Lung Res. 36 (1) (2010)
            epithelial integrity, Physiol. Rep. 5 (15) (2017), e13371.   31–44.
         [15] L.E. Jeffery, F. Burke, M. Mura, Y. Zheng, O.S. Qureshi, M. Hewison, L.S. Walker,   [37] A.V. Skalny, L. Rink, O.P. Ajsuvakova, M. Aschner, V.A. Gritsenko, S.I. Alekseenko,
            D.A. Lammas, K. Raza, D.M. Sansom, 1, 25-Dihydroxyvitamin D3 and IL-2 combine   A.A. Svistunov, D. Petrakis, D.A. Spandidos, J. Aaseth, Zinc and respiratory tract
            to inhibit T cell production of inflammatory cytokines and promote development of   infections: perspectives for COVID‑19, Int. J. Mol. Med. 46 (1) (2020) 17–26.
            regulatory T cells expressing CTLA-4 and FoxP3, J. Immunol. 183 (9) (2009)   [38] M. Razzaque, COVID-19 Pandemic: Can Maintaining Optimal Zinc Balance
            5458–5467.                                            Enhance Host Resistance?, 2020, pp. 175–181.
         [16] A. D’Avolio, V. Avataneo, A. Manca, J. Cusato, A. De Nicol` o, R. Lucchini, F. Keller,   [39] A.J. Te Velthuis, S.H. van den Worm, A.C. Sims, R.S. Baric, E.J. Snijder, M.J. van
            M. Cantù, 25-hydroxyvitamin d concentrations are lower in patients with positive   Hemert, Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in
            PCR for SARS-CoV-2, Nutrients 12 (5) (2020) 1359.     vitro and zinc ionophores block the replication of these viruses in cell culture, PLoS
         [17] E. Merzon, D. Tworowski, A. Gorohovski, S. Vinker, A. Golan Cohen, I. Green,   Pathog. 6 (11) (2010), e1001176.
            M. Frenkel Morgenstern, Low plasma 25(OH) vitamin D level is associated with   [40] M.T. Rahman, S.Z. Idid, Can Zn Be a Critical Element in COVID-19 Treatment? Biol.
            increased risk of COVID-19 infection: an Israeli population-based study, FEBS J.   Trace Elem. Res. (2020) 1–9.
            (2020), https://doi.org/10.1101/2020.07.01.20144329.   [41] E. Finzi, Treatment of SARS-CoV-2 with high dose oral zinc salts: a report on four
         [18] D.O. Meltzer, T.J. Best, H. Zhang, T. Vokes, V. Arora, J. Solway, Association of   patients, Int. J. Infect. Dis. (2020).
            vitamin d deficiency and treatment with COVID-19 incidence, medRxiv (2020),   [42] J. Ischia, High-dose Intravenous Zinc (HDIVZn) As Adjunctive Therapy in COVID-
            https://doi.org/10.1101/2020.05.08.20095893.          19 Positive Critically Ill Patients: a Pilot Randomized Controlled Trial, 2020. http
         [19] C.E. Hastie, D.F. Mackay, F. Ho, C.A. Celis-Morales, S.V. Katikireddi, C.   s://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379579&isRevie
            L. Niedzwiedz, B.D. Jani, P. Welsh, F.S. Mair, S.R. Gray, C.A. O’Donnell, J.M. Gill,   w=true.
            N. Sattar, J.P. Pell, Vitamin d concentrations and COVID-19 infection in UK   [43] R. Barazzoni, S.C. Bischoff, Z. Krznaric, M. Pirlich, P. Singer, ESPEN Expert
            biobank, Diabetes Metab. Syndr. 14 (4) (2020) 561–565.   Statements and Practical Guidance for Nutritional Management of Individuals With
         [20] Z. Raisi-Estabragh, C. McCracken, M.S. Bethell, J. Cooper, C. Cooper, M.   SARS-CoV-2 Infection, Elsevier, 2020, pp. 1631–1638.
            J. Caulfield, P.B. Munroe, N.C. Harvey, S.E. Petersen, Greater risk of severe COVID-   [44] M.M. Rogero, Md.C. Le˜ ao, T.M. Santana, M.Vd.M.B. Pimentel, G.C.G. Carlini, T.F.
            19 in Black, Asian and Minority Ethnic populations is not explained by   F. da Silveira, R.C. Gonçalves, I.A. Castro, Potential benefits and risks of omega-3
            cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D   fatty acids supplementation to patients with COVID-19, Free Radic. Biol. Med. 156
            status: study of 1326 cases from the UK Biobank, J. Public Health (Oxf.) (2020).   (2020) 190–199.
         [21] M. Braiman, Latitude Dependence of the COVID-19 Mortality Rate—A Possible   [45] J. Zhang, E.W. Taylor, K. Bennett, R. Saad, M.P. Rayman, Association between
            Relationship to Vitamin D Deficiency?, Available at SSRN 3561958, 2020.   regional selenium status and reported outcome of COVID-19 cases in China, Am. J.
         [22] M. Kara, T. Ekiz, V. Ricci,  ¨ O. Kara, K.V. Chang, L.  ¨ Ozçakar, ’SCientific Strabismus’   Clin. Nutr. 111 (6) (2020) 1297–1299.
            or two related pandemics: coronavirus disease and vitamin D deficiency, Br. J.   [46] D. Wu, S.N. Meydani, E. Vitamin, Immune Function, and Protection Against
            Nutr. (2020) 1–6.                                     Infection, Vitamin E in Human Health, Springer, 2019, pp. 371–384.
         [23] A. Daneshkhah, A. Eshein, H. Subramanian, H.K. Roy, V. Backman, The role of   [47] M. Kieliszek, B. Lipinski, Selenium supplementation in the prevention of
            vitamin d in suppressing cytokine storm in COVID-19 patients and associated   coronavirus infections (COVID-19), Med. Hypotheses 143 (2020), 109878.
            mortality, medRxiv (2020), https://doi.org/10.1101/2020.04.08.20058578.   [48] M. Liu, R. Wallin, A. Wallmon, T. Saldeen, Mixed tocopherols have a stronger
         [24] F.H. Lau, R. Majumder, R. Torabi, F. Saeg, R. Hoffman, J.D. Cirillo, P. Greiffenstein,   inhibitory effect on lipid peroxidation than alpha-tocopherol alone, J. Cardiovasc.
            Vitamin D insufficiency is prevalent in severe COVID-19, medRxiv (2020), https://   Pharmacol. 39 (5) (2002) 714–721.
            doi.org/10.1101/2020.04.24.20075838.              [49] Q. Dai, X. Zhu, J.E. Manson, Y. Song, X. Li, A.A. Franke, R.B. Costello, A. Rosanoff,
         [25] G. Panagiotou, S.A. Tee, Y. Ihsan, W. Athar, G. Marchitelli, D. Kelly, C.S. Boot,   H. Nian, L. Fan, H. Murff, R.M. Ness, D.L. Seidner, C. Yu, M.J. Shrubsole,
            N. Stock, J. Macfarlane, A.R. Martineau, G. Burns, R. Quinton, Low serum 25-   Magnesium status and supplementation influence vitamin D status and
            hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are   metabolism: results from a randomized trial, Am. J. Clin. Nutr. 108 (6) (2018)
            associated with greater disease severity, Clin. Endocrinol. (Oxf.) (2020) pre-print   1249–1258.
            ahead of publication.                             [50] T.C. Wallace, Combating COVID-19 and building immune resilience: a potential
         [26] L. Ferrucci, E. Fabbri, Inflammageing: chronic inflammation in ageing,   role for magnesium nutrition? J. Am. Coll. Nutr. (2020) 1–9.
            cardiovascular disease, and frailty, Nat. Rev. Cardiol. 15 (9) (2018) 505–522.   [51] S. Iotti, F. Wolf, A. Mazur, J.A. Maier, The COVID-19 pandemic: is there a role for
         [27] K. Razdan, K. Singh, D. Singh, Vitamin d levels and COVID-19 susceptibility: is   magnesium? Hypotheses and perspectives, Magn. Res. (2020).
            there any correlation? Med. Drug Discov. (2020), 100051.   [52] M.I.S. de Andrade, P.F.C. de Macˆ edo, T.L.P.S. de Oliveira, N.M. da Silva Lima, I. da
         [28] Y.-F. Zhou, B.-A. Luo, L.-L. Qin, The association between vitamin D deficiency and   Costa Ribeiro, T.M. Santos, Vitamin A and D deficiencies in the prognosis of
            community-acquired pneumonia: a meta-analysis of observational studies,   respiratory tract infections: A systematic review with perspectives for COVID-19
            Medicine 98 (38) (2019), e17252.                      and a critical analysis on supplementation.
         [29] J.I. Lee, G.J. Burckart, Nuclear factor kappa B: important transcription factor and   [53] K. Mikkelsen, V. Apostolopoulos, B vitamins and ageing, Subcell. Biochem. 90
            therapeutic target, J. Clin. Pharmacol. 38 (11) (1998) 981–993.   (2018) 451–470.
         [30] C. Hunt, N. Chakravorty, G. Annan, N. Habibzadeh, C. Schorah, The clinical effects   [54] K. Mikkelsen, L. Stojanovska, K. Tangalakis, M. Bosevski, V. Apostolopoulos,
            of vitamin C supplementation in elderly hospitalised patients with acute   Cognitive decline: a vitamin B perspective, Maturitas 93 (2016) 108–113.
            respiratory infections, Int. J. Vitam. Nutr. Res. 64 (3) (1994) 212–219.   [55] D. McCartney, D. Byrne, Optimisation of vitamin D status for enhanced Immuno-
         [31] L. Zhou, H. Xu, A Clinical Study for the Efficacy and Safety of Adalimumab   protection against Covid-19, Ir. Med. J. 113 (4) (2020) 58.
            Injection in the Treatment of Patients With Severe Novel Coronavirus Pneumonia   [56] H. Hemil¨ a, Vitamin C. and infections, Nutrients 9 (4) (2017) 339.
            (COVID-19), 2020. http://www.chictr.org.cn/showprojen.aspx?proj=49889.   [57] S. Rerksuppaphol, L. Rerksuppaphol, A randomized controlled trial of zinc
         [32] G. Hajishengallis, Too old to fight? Aging and its toll on innate immunity, Mol. Oral   supplementation in the treatment of acute respiratory tract infection in Thai
            Microbiol. 25 (1) (2010) 25–37.                       children, Pediatr. Rep. 11 (2) (2019) 7954.
         [33] R. Hiedra, K.B. Lo, M. Elbashabsheh, F. Gul, R.M. Wright, J. Albano,   [58] H. Hemil¨ a, Vitamin E administration may decrease the incidence of pneumonia in
            Z. Azmaiprashvili, G. Patarroyo Aponte, The use of IV vitamin C for patients with   elderly males, Clin. Interv. Aging 11 (2016) 1379.
            COVID-19: a single center observational study, Expert Rev. Anti. Ther. (2020).   [59] C.M. Lemoine S, E.P. Brigham, H. Woo, C.K. Hanson, M.C. McCormack, A. Koch,
         [34] H.M. Waqas Khan, N. Parikh, S.M. Megala, G.S. Predeteanu, Unusual early   N. Putcha, N.N. Hansel, Omega-3 fatty acid intake and prevalent respiratory
            recovery of a critical COVID-19 patient after administration of intravenous vitamin   symptoms among U.S. Adults with COPD, BMC Pulm. Med. 19 (1) (2019) 97.
            C, Am. J. Case Rep. 21 (2020), e925521.           [60] National Health and Medical Research Council, Nutrient Reference Values for
                                                                  Australia and New Zealand: Including Recommended Dietary Intakes, 2006.

















                                                            9
   12   13   14   15   16   17   18   19   20